SMS Pharmaceuticals clears USFDA inspection at Vizag API plant with one minor observation
SMS Pharmaceuticals Ltd completes USFDA inspection at Visakhapatnam API facility with minor observation, reinforcing global quality and compliance standards. Shares of SMS Pharmaceuticals Ltd ended lower on Friday, December 12, by 0.23% at ₹320.15 on the NSE.